Owlstone Medical presents data demonstrating progress in development of breath biopsy tests for liver cirrhosis and NASH

FHS
June 22, 2023
12:03 pm

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced new data on the development of novel tests for the detection of liver disease.

FDA grants orphan drug status to Ionis’ olezarsen for FCS

Share this article Olezarsen is currently undergoing evaluation for individuals at risk of diseases caused by elevated triglyceride levels, including FCS. Credit: metamorworks / Shutterstock.com.

February 16, 2024

Seres Therapeutics sheds about 160 jobs to focus on commercial C. diff pill

Seres Therapeutics will end most R&D work to focus resources on its commercial product in a move that will result in letting go about 160

November 3, 2023

STAT Morning Rounds: Six health news stories you need to start your day

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. How sickle cell became the first

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.